Kinshasa, DR Congo / RankWire.AI / – In the Democratic Republic of the Congo, health authorities have confirmed that the total number of infections has reached 3,075, marking a sharp increase in the ongoing epidemic as Congo Ebola cases cross 3,000. The outbreak has resulted in 1,354 deaths and 556 recoveries, with 755 patients currently hospitalized or isolated in specialized facilities. Declared on May 15, this epidemic is the fastest-growing Ebola outbreak on record, adding 1,000 new cases in less than two weeks after surpassing 2,000 cases on July 15.
The surge is primarily driven by the Bundibugyo strain of the Ebola virus, a rare variant for which no approved vaccines or targeted antiviral treatments currently exist. On May 17, the World Health Organization declared the outbreak in the Democratic Republic of the Congo and neighboring Uganda a public health emergency of international concern. Experts assess that the risk of regional transmission remains high due to cross-border population movements and ongoing conflict in affected areas. Epidemiological data show that nearly 90 percent of confirmed cases are concentrated in the northeastern province of Ituri, which borders South Sudan and Uganda.
During a briefing on the emergency response, Dr. Jean Kaseya, Director General of the Africa Centres for Disease Control and Prevention, highlighted the critical challenges faced by frontline health workers. He noted that many patients are dying because of severe shortages of specialized medical therapeutics, protective gear, and international financial support. The current outbreak has claimed lives at a faster rate than the West Africa epidemic from 2013 to 2016, which took over 11,000 lives over two years. While previous outbreaks took about eight months to reach 1,000 fatalities, the Bundibugyo strain has surpassed this milestone in just ten weeks.
Characteristics and Obstacles of the Bundibugyo Strain
Response efforts across regional treatment centers have been severely hampered by ongoing strikes among local healthcare workers demanding unpaid wages. DRC health officials explained that although increased diagnostic capabilities and expanded field testing have improved case detection, administrative delays and logistical issues hinder containment. Hospitals in eastern provinces continue to press the government for immediate disbursement of risk allowances and operational funds. Public health leaders warn that ongoing strikes within isolation facilities could accelerate community transmission, especially in rural areas nearby.
With no targeted medical countermeasures available yet, international scientific groups are accelerating trials of potential vaccines. Researchers at Oxford University have confirmed that a first group of human volunteers has received an experimental vaccine designed specifically to combat the Bundibugyo strain. Meanwhile, neighboring East African countries have increased border screening and distributed personal protective equipment at transit hubs. These governments are working closely with international partners to prevent secondary transmission chains within major urban transit points.
Emergency Declaration Spreads Across Central Africa
Models reviewed by global health agencies indicate that the epidemic could persist for several more months before reaching a peak. International humanitarian organizations continue to organize specialized medical airlifts, delivering diagnostic reagents, protective gear, and hydration supplies to regional hospitals. Experts emphasize that establishing stable supply lines to remote treatment sites is crucial to reducing fatalities. Field teams are also intensifying community outreach to improve contact tracing and address public mistrust of medical isolation measures.
Global health authorities stress that controlling the outbreak requires ongoing international financial aid and immediate medical supply distribution. The emergency strategy prioritizes strengthening local clinical capacities, ensuring healthcare worker compensation, and deploying experimental vaccines under emergency protocols. Authorities maintain that rapid deployment of experimental therapeutics combined with effective contact tracing is essential to halt regional virus spread and safeguard vulnerable populations across Africa.